Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1986-12-15
1988-02-23
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
424DIG5, 514859, 514863, A61K 748, A61K 3120
Patent
active
047270888
ABSTRACT:
A new and improved topically applied pharmaceutical preparation for the treatment of acne and an improved vehicle for delivering the active ingredients thereof to the human skin in a manner whereby the bioavailability and percutaneous absorption of the active ingredient is remarkably enhanced. The vehicle comprises a volatile silicone, a fatty alcohol having from 12-22 carbon atoms, retinoids selected from the group consisting of tretinoin (all-trans retinoic acid) and isotretinoin (13-cis retinoic acid); and such preservatives or emulsifying agents as may be warranted.
REFERENCES:
patent: 4022913 (1977-05-01), Newmark
patent: 4603146 (1986-07-01), Kligman
Jungermann Eric
Scott Richard A.
Wortzman Mitchell S.
Mybeck Richard R.
Neutrogena Corporation
Ore Dale R.
LandOfFree
Retinoid composition having enhanced bioavailability and percuta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoid composition having enhanced bioavailability and percuta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoid composition having enhanced bioavailability and percuta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-603124